SCHEMBL14226940

SCHEMBL14226940

O=c1n(SOOC2(C[C@H](COCc3ccccc3)OCc3ccccc3)CC2)c2c3occc3c(F)c(F)c2n1-c1ccc(I)cc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14226939 1.00 — —
SCHEMBL14151741 0.87 — —
SCHEMBL14151740 0.87 — —
SCHEMBL14241606 0.82 — —
SCHEMBL14241607 0.82 — —
SCHEMBL14151600 0.72 MAP2K1 (0.36) —
SCHEMBL14151601 0.72 MAP2K1 (0.36) —
SCHEMBL12540071 0.71 — —
SCHEMBL14241152 0.68 MAP2K1 (0.44) —
SCHEMBL14151627 0.68 MAP2K1 (0.44) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470878-B2 Heterocyclic sulfonamide derivatives NOVARTIS AG (CH) 2013-06-25 — — US disclosed
US-20120316149-A1 HETEROCYCLIC SULFONAMIDE DERIVATIVES AURIGENE DISCOVERY TECHNOLOGIES LIMITED (IN) 2012-12-13 — — US disclosed
Send feedback